Impact of obesity on breast cancer recurrence and minimal residual disease

被引:0
|
作者
Brett L. Ecker
Jun Y. Lee
Christopher J. Sterner
Aaron C. Solomon
Dhruv K. Pant
Fei Shen
Javier Peraza
Lauren Vaught
Samyukta Mahendra
George K. Belka
Tien-chi Pan
Kathryn H. Schmitz
Lewis A. Chodosh
机构
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Surgery
[2] Perelman School of Medicine at the University of Pennsylvania,Department of Cancer Biology
[3] Abramson Cancer Center,2
[4] University of Pennsylvania,PREVENT Translational Center of Excellence
[5] Perelman School of Medicine at the University of Pennsylvania,The Abramson Family Cancer Research Institute
[6] Penn State College of Medicine,Penn State Cancer Institute
来源
关键词
Obesity; High-fat diet; Breast cancer; Recurrence; Tumor dormancy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Minimal Residual Disease in Breast Cancer: Can It Be Used as a Prognostic Marker?
    T. Liakakos
    Annals of Surgical Oncology, 2008, 15 : 1793 - 1794
  • [22] Global evaluation of minimal residual disease in primary breast cancer patients
    Lucci, A., Jr.
    Krishnamurthy, S.
    Mosalpuria, K.
    Bedrosian, I.
    Meric-Bernstam, F.
    Reuben, J. M.
    Singh, B.
    Woodward, W. A.
    Cristofanilli, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay
    Janni, W.
    Rack, B.
    Friedl, T. W. P.
    Hartkopf, A. D.
    Wiesmueller, L.
    Pfister, K.
    Mergel, F.
    Fink, A.
    Braun, T.
    Mehmeti, F.
    Uhl, N.
    De Gregorio, A.
    Huober, J.
    Fehm, T.
    Mueller, V.
    Rich, T. A.
    Dustin, D. J.
    Zhang, S.
    Huesmann, S. T.
    ESMO OPEN, 2025, 10 (04)
  • [24] Minimal residual disease in breast cancer: detection and genomic characterization of disseminated cancer cells
    Killinger, K.
    Schneider, E.
    Schmidt, O.
    Czyz, Z.
    Patwary, N.
    Haunschild, G.
    Rack, B.
    Schlimok, G.
    Klein, C. A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E42 - E42
  • [25] Minimal Residual Disease in Prostate Cancer
    Cackowski, Frank C.
    Taichman, Russell S.
    BIOLOGICAL MECHANISMS OF MINIMAL RESIDUAL DISEASE AND SYSTEMIC CANCER, 2018, 1100 : 47 - 53
  • [26] Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
    Tachtsidis, A.
    McInnes, L. M.
    Jacobsen, N.
    Thompson, E. W.
    Saunders, C. M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (06) : 521 - 550
  • [27] Minimal residual disease in breast cancer and gynecological malignancies: Phenotype and clinical relevance
    Roggel, F
    Hocke, S
    Lindemann, K
    Sinz, S
    Welk, A
    Bosl, M
    Pabst, M
    Nusser, N
    Braun, S
    Schmitt, M
    Harbeck, N
    MOLECULAR STAGING OF CANCER, 2003, 162 : 89 - 100
  • [28] Cancer: Targeting minimal residual disease
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2018, 17 (9) : 622 - 622
  • [29] Minimal residual disease in gastric cancer
    Seeliger, H
    Spatz, H
    Jauch, KW
    MOLECULAR STAGING OF CANCER, 2003, 162 : 79 - 87
  • [30] Clinical Applications for Liquid Biopsy Assessment of Minimal Residual Disease in Breast Cancer
    Sears, James J.
    Davis, Andrew A.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 252 - 265